This content is machine translated Hidradenitis suppurativa/acne inversa Relieving suffering and inflammation – how can this be achieved? Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling...…
View Post 18 min This content is machine translated Hidradenitis suppurativa/acne inversa Challenges of outpatient care The disease hidradenitis suppurativa/acne inversa was first mentioned in 1839 with superficial abscesses on the axillary, submammary and perianal regions. To date, the disease has had various names: Perifolliculitis capitis… CME-Test
View Post 15 min This content is machine translated Hidradenitis suppurativa Etiopathogenesis, diagnosis and treatment – an update The pathogenesis of hidradenitis suppurativa (HS) has not yet been fully clarified; it is assumed that there are multifactorial interactions. The most important risk factors and comorbidities include smoking, obesity… CME-Test
View Post 5 min This content is machine translated Hidradenitis suppurativa Treatment options – status quo and outlook The management of hidradenitis suppurativa remains a clinical challenge. A combination of different therapeutic modalities is often required to achieve a sufficient degree of disease control. One study demonstrated that…
View Post 4 min This content is machine translated Biologics for psoriasis “Drug Survival” under the microscope The era of biologics has revolutionized the treatment options for patients with moderate to severe psoriasis in recent decades. Drug survival is an indicator of the longer-term efficacy and safety…
View Post 8 min This content is machine translated Plaque psoriasis Updated guideline recommendations for children and adolescents Early treatment in children and adolescents with psoriasis is an important supply target. The updated s2k guideline provides evidence-based decision support for the selection of appropriate therapy. In the new edition…
View Post 4 min This content is machine translated Hidradenitis suppurativa: study report Successful treatment demonstrably improves quality of life Adalimumab (anti-TNF-α) is currently still the only approved biologic for the treatment of moderate to severe hidradenitis suppurativa (HS). In a recent “real world” 52-week study, treatment with adalimumab resulted…
View Post 9 min This content is machine translated Plaque psoriasis Current therapeutic aspects An update on therapies currently available for plaque psoriasis. The introduction of biologics has changed the way patients with moderate to severe psoriasis are treated – with far-reaching implications for…
View Post 5 min This content is machine translated Pediatric dermatology Genetics does not replace the clinical view The large number of already known genetic causes of dermatological diseases could lead to the conclusion that in the future diagnoses will be made by genetic analysis alone. However, the…
View Post 4 min This content is machine translated Juvenile idiopathic arthritis Aggressive combination therapy leads to faster disease inactivity Juvenile idiopathic arthritis (JIA), also called juvenile rheumatoid arthritis, is a collective term for several forms of arthritis, all of which involve chronic long-term joint inflammation. This inflammation begins in…
View Post 6 min This content is machine translated Highlights EULAR Wide variety of therapeutic options On the third day of this year’s EULAR Congress, news was presented in the areas of fibromyalgia, juvenile idiopathic arthritis, psoriatic arthritis and osteoarthritis. Experts from four different countries presented…
